Your browser doesn't support javascript.
loading
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib.
Sharma, Geeta G; Cortinovis, Diego; Agustoni, Francesco; Arosio, Giulia; Villa, Matteo; Cordani, Nicoletta; Bidoli, Paolo; Bisson, William H; Pagni, Fabio; Piazza, Rocco; Gambacorti-Passerini, Carlo; Mologni, Luca.
Afiliación
  • Sharma GG; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; European Research Initiative for ALK-Related Malignancies, Cambridge, United Kingdom. Electronic address: geeta.geeta@unimib.it.
  • Cortinovis D; Department of Oncology, San Gerardo Hospital, Monza, Italy.
  • Agustoni F; Department of Oncology, San Gerardo Hospital, Monza, Italy.
  • Arosio G; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Villa M; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Cordani N; Haematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy.
  • Bidoli P; Department of Oncology, San Gerardo Hospital, Monza, Italy.
  • Bisson WH; Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Pagni F; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; Haematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy.
  • Piazza R; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; Haematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy.
  • Gambacorti-Passerini C; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; European Research Initiative for ALK-Related Malignancies, Haematology, Cambridge, United Kingdom and Clinical Research Unit, San Gerardo Hospital, Monza, Italy.
  • Mologni L; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; European Research Initiative for ALK-Related Malignancies.
J Thorac Oncol ; 14(11): e257-e259, 2019 11.
Article en En | MEDLINE | ID: mdl-31668326
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos Organofosforados / Pirimidinas / Carcinoma de Pulmón de Células no Pequeñas / Lactamas Macrocíclicas / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares / Mutación Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: J Thorac Oncol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Compuestos Organofosforados / Pirimidinas / Carcinoma de Pulmón de Células no Pequeñas / Lactamas Macrocíclicas / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares / Mutación Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: J Thorac Oncol Año: 2019 Tipo del documento: Article